January 30: The Week in Cancer News
Older adults with metastatic cancer are spending more time at medical appointments, and a biomarker test improves the odds of detecting pancreatic cancer.
Progress Against Cancer
Older adults with metastatic cancer are spending more time at medical appointments, and a biomarker test improves the odds of detecting pancreatic cancer.
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power of tissue and liquid biopsy all have in common? They are all at the heart...
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
The countdown to the new year is nearly upon us, but no need to count down to the last installment of Editors’ Picks in 2025 … because here it is! With articles on everything...
Immune checkpoint inhibitor improves survival in people with limited-stage small cell lung cancer.
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast cancer care.
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged in 2025.
Clinical trial presented at SABCS finds some patients may safely skip sentinel lymph node biopsy.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More